ZDHHC9 and breast carcinoma: Our results indicated that high expression of ZDHHC9 had a negative effect on OS, relapse-free survival (RFS), disease-specific survival (DSS) and progression-free survival (PFS) in breast cancer patients in a multi-centre retrospective cohort (Fig. 7E).